Skip to main content

Advertisement

Log in

Effect of Oral Chinese Medicine Combined with Western Medicine on Cancer Pain: A Meta-Analysis

  • Evidence-Based Integrative Medicine
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To assess the effect of oral Chinese medicine (OCM) combined with Western medicine (WM) on cancer pain.

Methods

PubMed, Embase, Cochrane Library, Clinical Trials Registry Platform, Chinese National Knowledge Infrastructure (CNKI), Wanfang and VIP databases were searched from their inception to September {dy2019}. Randomized controlled trials (RCTs) treating cancer pain by Chinese medicine (CM) combined with WM were included. The primary outcome were total pain relief rate and the quality of life (QOL), and the other outcomes were the average daily dosage of analgesics, the primary time of pain, the analgesic duration time, and adverse events. The methodological quality of RCTs was assessed in accordance with Cochrane 5.1.0 handbook of systematic reviews of interventions. Evidence level was assessed by the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach.

Results

There were 1,087 patients in the 14 studies, with 544 in the experiment group and 543 in the control group. These studies were all conducted in China, and published between 2006 and {dy2019}. Compared with the WM, OCM combined with WM could significantly relieve the cancer pain [risk ratio (RR)=1.43, 95% confidence interval (CI): 1.32, 1.56), improve QOL (RR=8.57, 95% CI: 4.25, 12.89), decrease the primary time of pain (RR=−0.20, 95% CI: −0.24, −0.16], prolong the analgesic duration time (RR=3.47, 95% CI: 2.09, 4.85), reduce the dosage of analgesics (RR=−19.52, 95% CI: −36.32, −2.72), and reduce side events (RR=0.49, 95% CI: 0.37, 0.65). Evidence levels for total pain relief rate, primary time of pain and side events were low, evidence level for QOL, analgesic duration time and average daily dosage of analgesics were very low.

Conclusions

Compared with the WM, OCM combined with WM could significantly relieve the cancer pain, improve the QOL, decrease the primary time of pain, prolong the analgesic duration time, reduce the dosage of analgesics and side events. The evidence levels were low or very low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balding L. The World Health Organisation analgesic ladder: its place in modern Irish medical practice. Ir Med J 2013;106:122–124.

    CAS  PubMed  Google Scholar 

  2. Gaertner J, Schiessl C. Cancer pain management: what’s new? Curr Pain Headache Rep 2013;17:328.

    Article  Google Scholar 

  3. Marcus DA. Epidemiology of cancer pain. Curr Pain Headache Rep 2011;15:231–234.

    Article  Google Scholar 

  4. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007;18:1437–1449.

    Article  CAS  Google Scholar 

  5. Quinten C, Coens C, Mauer M, Comte S, Spranger MAG, Cleeland C, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009;10:865–871.

    Article  Google Scholar 

  6. Efficace F, Bottomley A, Smit EF, Lianes P, Legradn C, Debruyne C, et al. Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol 2006;17:1698–1704.

    Article  CAS  Google Scholar 

  7. Hao TT, Wu Y, Tao ZJ, An BP. Treatment of cancer pain by Chaihu Guizhi Formula. J Tradit Chin Med (Chin) 2015;56:1067–1068.

    Google Scholar 

  8. Shang ZJ, Shang YH. Clinical study on oxycodone hydrochloride injection combined with the method of activating blood and removing blood stasis in cancer pain patients. Inf Tradit Chin Med (Chin) 2016;33:92–93.

    Google Scholar 

  9. Cai B, Wang JL. Effect of Ergusan with zoledronic acid on bone metastases and quality of life and cancer pain. Modern J Integr Tradit Chin West Med (Chin) 2017;25:3373–3375.

    Google Scholar 

  10. World Health Organization. Cancer pain relief. 2nd ed. Geneva: World Health Organization; 1996:1–8.

    Google Scholar 

  11. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration. 2011. Available at: http://www.handbook-5-1.cochrane.org.

    Google Scholar 

  12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.

    Article  Google Scholar 

  13. Review Manager (RevMan) Computer program. Version 5.0. Copenhagen: The Nordic Cochrane Cencer, The Cochrane Collaboration; 2008.

  14. Ye X, Lu D, Chen X, Li S, Chen Y, Deng L. Multicenter, randomized, double-blind,placebo-controlled trial of shuangbai San for treatingprimary liver cancer patients with cancer pain. J Pain Symptom Manage 2016;51:979–986.

    Article  Google Scholar 

  15. Zhai JL. Clinical study of Bushen Huayu Huoxue Receipe on metastatic bone tumors with syndrome of kidney deficiency, phlegm coagulation, and blood stasis. [dissertation]. Zhengzhou: Henan University of Chinese Medicine; 2015.

    Google Scholar 

  16. Yuan MM. Guliukang granule in treating Bone Metastases with kidney deficiency and for effects of serum BSP [dissertation]. Zhengzhou: Henan University of Chinese Medicine; 2014.

    Google Scholar 

  17. Wang K. Clinical observation on the effect of treating bone metastasis of kidney deficiency type of breast cancer with Yishen Decoction [dissertation]. Zhengzhou: Henan University of Chinese Medicine; 2015.

    Google Scholar 

  18. Wang YJ. Clinical study of Fuzheng jiedu huayu in treating cancer body pain [dissertation]. Beijing, Beijing University of traditional Chinese medicine; 2016.

    Google Scholar 

  19. Chen X, Zhang HB, Liu YH, Zhu YJ, Li Y, Bai JP, et al. Effect of Hugu Xiaoji formula combined with zoledronic acid on bone cancer pain and correlation between NTx level and kidney deficiency syndrome in TCM. J New Chin Med (Chin) 2017;49:117–120.

    CAS  Google Scholar 

  20. Zhang P. Clinical study of Yishen Gukang Formular on bone cancer pain and the mechanism of bone metastase [dissertation]. Beijing: China Academy of Chinese Medical Sciences; 2013.

    Google Scholar 

  21. Luo Y. The effect of adverse events of opioid analgesics in cancer pain patients in TCM treatment. J Sichuan Tradit Chin Med (Chin) 2009;27:68–69.

    Google Scholar 

  22. Zhang Y. Analgesic effect and mechanism of CQ compound on rats with tibial metastatic cancer pain [dissertation]. Beijing: China Academy of Chinese Medical Sciences; 2014.

    Google Scholar 

  23. Lu W. Clinical study on Aitongping Capsule in treating cancerous pain and further explore on the mechanism of effect [dissertation]. Nanjing: Nanjing University of Traditional Chinese Medicine; 2012.

    Google Scholar 

  24. Zhang T, Ma SL, Xie GR, Deng QH, Tang ZZ, Pan XC, et al. Clinical research on Nourising Yin and Unblocking Meridians Recipe combined with opiod analgesics in cancer pain management. Chin J Integr Med 2006;12:180–184.

    Article  Google Scholar 

  25. Cong Y, Sun KF, He XM, Li JX, Dong YB, Zheng B, et al. A traditional Chinese medicine Xiao-Ai-Tong suppresses pain through modulation of cytokines and prevents adverse reactions of morphine treatment in bone cancer pain patients. Mediators Inflamm 2015;2015:961635.

    Article  Google Scholar 

  26. Hao W, Chen L, Wu LF, Yang F, Niu JX, Alan DK, et al. Tanshinone II A exerts an antinociceptive effect in rats with cancer-induced bone pain. Pain Physician 2016;19:465–476.

    PubMed  Google Scholar 

  27. Wang JY, Zhang RX, Dong CS, Jiao LY, Xua L, Liu JY, et al. Topical treatment with Tong-Luo-San-Jie Gel alleviates bone cancer pain in rats. Ethnopharmacol 2012;143:905–913.

    Article  Google Scholar 

  28. Chen T, Yuan SJ, Wan XN, Zhan L, Yu XQ, Zeng JH, et al. Chinese herb cinobufagin-reduced cancer pain is associated with increased peripheral opioids by invaded CD3/4/8 lymphocytes. Oncotarget 2017;8:11425–11441.

    Article  Google Scholar 

  29. Wang J. Clinical study of Xinjialiangfu Granule in the treatment of advanced gastric cancer [dissertation]. Beijing. Beijing University of Chinese Traditional Medicine; 2010.

    Google Scholar 

  30. Miu YD, Quan WX. Clinical observation of Huachansu capsule in the treatment of cancer pain. Chin Tradit Patent Med (Chin) 2018;40:2107–2110.

    Google Scholar 

  31. Dong XS, Li YH, Zhang YJ, Zhao Y, Wu SL, Xiao YX. Curative effect of morphine sulfate sustained-release tablets combined with Huachansu Capsules on cancer pain. Chin Commun Doctors (Chin) 2018;34:84–87.

    Google Scholar 

  32. Song HL, Yin YK, Wang YH, Liu LX, Zhou L, Feng L. Clinical efficacy and safety of Yishen Gukang prescription combined with oxycontin in the treatment of moderate and severe cancer somatic pain. Chin J Exp Tradit Med Formul (Chin) 2018;24:164–168.

    Google Scholar 

  33. Ouyang XQ. Treatment of 43 cases of cancer pain caused by yang deficiency and cold coagulation by combination of Peony and Aconite Decoction. China Naturopathy (Chin) 2018;26(13):72–74.

    Google Scholar 

  34. Bao PQ. Clinical observation of Xuefu Zhuyu Decoction combined with morphine sulfate sustained-release tablets in the treatment of cancer pain in advanced stage. J Pract Tradit Chin Med (Chin) 2018;34:591–592.

    Google Scholar 

  35. Wang XL, Li JT. Clinical observation of self-made Suanji Zhitong Decoction combined with oxycodone hydrochloride in the treatment of moderate and severe cancer pain. J Emerg Tradit Chin Med (Chin) 2019;28:331–334.

    Google Scholar 

  36. Ayibaota Nvlalemu. Clinical study on modified Chaihu Shugan San in the treatment of cancer pain of liver cancer with Liver depression and qi stagnation [dissertation]. Urumqi: Xijiang Medicine University; 2018.

    Google Scholar 

  37. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recom mendations. BMJ 2008;336:924–926

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Feng.

Ethics declarations

The authors declared that they have no conflicts of interest to this work.

Additional information

Supported by National Natural Science Foundation of China (No. 81873283)

Supplementary material to

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Yh., Chang, Jy. & Feng, L. Effect of Oral Chinese Medicine Combined with Western Medicine on Cancer Pain: A Meta-Analysis. Chin. J. Integr. Med. 27, 713–720 (2021). https://doi.org/10.1007/s11655-020-3423-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-020-3423-x

Keywords

Navigation